12 December 2019:
LeanTaaS, Inc., today announced it has closed a $40 million Series C round of funding from Goldman Sachs’ Merchant Banking Division.
The company will use the fresh capital to fund the continued expansion of the LeanTaaS iQueue platform, which currently consists of three solutions: iQueue for Infusion Centers, iQueue for Operating Rooms and iQueue for Clinics. The company will also use the fund to significantly accelerate the hiring of key leaders in roles throughout the company including engineering, data science, product management, sales, and marketing.
Mohan Giridharadas, Founder and CEO of LeanTaaS, said, “With Goldman Sachs and Insight Partners as our two major financial investors, we continue to strengthen our access to an incredibly diverse set of resources including expertise, network and funding to accelerate the pace at which we help hospitals and healthcare providers bend their access and cost curves.”
Antoine Munfa, a managing director with Goldman Sachs’ Merchant Banking Division, said, “LeanTaaS has developed a powerful prescriptive analytics platform that helps bend the access and cost curves in health systems, enabling customers to achieve tangible operational improvements.
Paul Pate, a vice president with Goldman Sachs’ Merchant Banking Division, said, “LeanTaaS delivers its platform as scalable, web-based software which can be configured to serve a wide array of healthcare environments.”
“LeanTaaS’ iQueue represents a rare nexus of product leadership, robust ROI, and fast time to value for hospitals. As software-focused investors, we have found the product’s impact on customers to be very impressive in general, but in particular considering how hard it is to deliver value with true SaaS products in healthcare environments,” said Peter Segall, former healthcare IT CEO and now managing director at Insight Partners.
(Image – LeanTaas)